Healing Starts with a Frequency
EMulate Therapeutics uses ultra-low radio frequency energy to influence cell behavior and support targeted therapeutic outcomes.
Explore the Technology
EMulate's proprietary ulRFE® technology provides non-ionizing, non-invasive, non-thermal therapy designed to emulate the activity of validated molecules—without delivering the molecules themselves.
Advancing therapies for some of the most difficult-to-treat brain cancers.
Targets:
Regulatory Status:
Developing signal-based interventions for neuropsychiatric conditions.
Targets:
Regulatory Status:
Non-opioid, non-pharmacologic pain modulation for humans and animals.
Targets:
Regulatory Status:
EMulate Therapeutics uses ultra-low radio frequency energy to influence cell behavior and support targeted therapeutic outcomes.
We identify and capture the electromagnetic behavior of therapeutic molecules.
These encoded signatures are transmitted into the body through a wearable device.
Cells interpret the signals as if the molecules themselves were present.
Targeted pathways become active, supporting restoration, balance, and recovery.
Participate through Wefunder, our current platform for engaging new investors.
Our equity crowdfunding round on Wefunder is open to both accredited and non-accredited investors. This campaign supports our clinical progress, technology expansion, and near-term commercialization efforts.
Invest on WeFunderNeurological and mental-health therapeutics targeting brain function and cognitive balance.
Stay connected and get the latest company news delivered to your inbox.